POCARE

Serial Number 99016338
645

Registration Progress

Application Filed
Jan 23, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Jan 08, 2026 14 days

Trademark Image

POCARE

Basic Information

Serial Number
99016338
Filing Date
January 23, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
645
Status Date
Oct 8, 2025
Application
Pending
Classes
005 042

Rights Holder

OCTOMERA LLC

16
Address
1812 Ashland Avenue
Unit Lower Level Lab G09
Baltimore, MD 21205

Ownership History

OCTOMERA LLC

Original Applicant
16
Baltimore, MD

Legal Representation

Attorney
JACQUELINE ZION

USPTO Deadlines

Next Deadline
14 days remaining
Final Refusal E-Mailed
Due Date
January 08, 2026
Extension Available
Until April 08, 2026

Application History

16 events
Date Code Type Description Documents
Dec 22, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 22, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 22, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 8, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 8, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 8, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 3, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 3, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 3, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 23, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 23, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders
Class 042
Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; development of cell therapy products; development of technologies for the manufacture and processing of cells to be used as part of advance cell therapies

Classification

International Classes
005 042